Showing results (351-360 of 858) with videos related to
Sort By:
Pageof 86
Life Science Alliance|August 30, 2023
Polo-like kinase-1 mediates hepatitis C virus-induced cell migration, a drug target for liver cancerKorri E El-Khobar, Enoch Tay, Eve Diefenbach, et al.Journal of Clinical Epidemiology|August 16, 2014
Side effects are incompletely reported among systematic reviews in gastroenterologySuzanne E Mahady, Timothy Schlub, Lisa Bero, et al.Plos One|May 25, 2016
Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular CarcinomaRoslyn Vongsuvanh, David van der Poorten, Tristan Iseli, et al.Journal of Hepatology|July 13, 2016
Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based studyMaryam Alavi, Matthew G Law, Jason Grebely, et al.Experimental and Molecular Pathology|May 6, 2004
The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditisJacob George, Iris Barshack, Iris Goldberg, et al.Circulation|May 22, 2002
Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout miceJacob George, Arnon Afek, Pnina Keren, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 2005
Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout miceJacob George, Arnon Afek, Anastasia Abashidze, et al.Hepatology (Baltimore, Md.)|November 30, 2006
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosisElisabetta Bugianesi, Gulio Marchesini, Elena Gentilcore, et al.Hepatology (Baltimore, Md.)|July 30, 2011
Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?Hossein Poustchi, Geoffrey C Farrell, Simone I Strasser, et al.Journal of Diabetes and Its Complications|July 5, 2021
The prevalence of gestational diabetes mellitus in women diagnosed with non-alcoholic fatty liver disease during pregnancy: A systematic review and meta-analysisThora Ying Li Chai, Romesh Mark Rajaratnam, Difei Deng, et al.Pageof 86